These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 36982559)

  • 21. Maternal Immune Activation Causes Schizophrenia-like Behaviors in the Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic Pathways, and Lowered Antioxidant Defenses and Neuroprotection.
    Talukdar PM; Abdul F; Maes M; Binu VS; Venkatasubramanian G; Kutty BM; Debnath M
    Mol Neurobiol; 2020 Oct; 57(10):4345-4361. PubMed ID: 32720073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review.
    Han VX; Patel S; Jones HF; Nielsen TC; Mohammad SS; Hofer MJ; Gold W; Brilot F; Lain SJ; Nassar N; Dale RC
    Transl Psychiatry; 2021 Jan; 11(1):71. PubMed ID: 33479207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders.
    Beversdorf DQ; Stevens HE; Jones KL
    Curr Psychiatry Rep; 2018 Aug; 20(9):76. PubMed ID: 30094645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders.
    Trifonova EA; Mustafin ZS; Lashin SA; Kochetov AV
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder.
    Lombardo MV; Moon HM; Su J; Palmer TD; Courchesne E; Pramparo T
    Mol Psychiatry; 2018 Apr; 23(4):1001-1013. PubMed ID: 28322282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal maternal stress and the severity of autism spectrum disorder: A cross-sectional study.
    Alamoudi RA; Al-Jabri BA; Alsulami MA; Sabbagh HJ
    Dev Psychobiol; 2023 Mar; 65(2):e22369. PubMed ID: 36811367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder.
    Gevezova M; Sarafian V; Anderson G; Maes M
    CNS Neurol Disord Drug Targets; 2020; 19(5):320-333. PubMed ID: 32600237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of immune and metabolism pathways in maternal immune activation induces an increased risk of autism spectrum disorders.
    Yin H; Wang Z; Liu J; Li Y; Liu L; Huang P; Wang W; Shan Z; Sun R; Shen J; Duan L
    Life Sci; 2023 Jul; 324():121734. PubMed ID: 37105442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats.
    Viana CE; Bortolotto VC; Araujo SM; Dahleh MMM; Machado FR; de Souza Pereira A; Moreira de Oliveira BP; Leimann FV; Gonçalves OH; Prigol M; Guerra GP
    Neurotoxicology; 2023 Jan; 94():223-234. PubMed ID: 36528186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD).
    Hughes HK; R J Moreno ; Ashwood P
    Brain Behav Immun; 2023 Feb; 108():245-254. PubMed ID: 36494048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal stress and fluoxetine exposure in mice differentially affect repetitive behaviors and synaptic plasticity in adult male and female offspring.
    Arzuaga AL; Edmison DD; Mroczek J; Larson J; Ragozzino ME
    Behav Brain Res; 2023 Jan; 436():114114. PubMed ID: 36116737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia.
    Guma E; Plitman E; Chakravarty MM
    Neurosci Biobehav Rev; 2019 Sep; 104():141-157. PubMed ID: 31265870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal exposure to fever is associated with autism spectrum disorder in the boston birth cohort.
    Brucato M; Ladd-Acosta C; Li M; Caruso D; Hong X; Kaczaniuk J; Stuart EA; Fallin MD; Wang X
    Autism Res; 2017 Nov; 10(11):1878-1890. PubMed ID: 28799289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders.
    Shao W; Su Y; Liu J; Liu Y; Zhao J; Fan X
    Diabetes Metab; 2024 Jul; 50(4):101543. PubMed ID: 38761920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalk Between the Microbiome and Gestational Immunity in Autism-Related Disorders.
    Paysour MJ; Bolte AC; Lukens JR
    DNA Cell Biol; 2019 May; 38(5):405-409. PubMed ID: 30817175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photobiomodulation Attenuated Cognitive Dysfunction and Neuroinflammation in a Prenatal Valproic Acid-Induced Autism Spectrum Disorder Mouse Model.
    Kim UJ; Hong N; Ahn JC
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative Stress, Maternal Diabetes, and Autism Spectrum Disorders.
    Carpita B; Muti D; Dell'Osso L
    Oxid Med Cell Longev; 2018; 2018():3717215. PubMed ID: 30524654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Autism Res; 2021 Nov; 14(11):2270-2286. PubMed ID: 34415116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relationship between Autism Spectrum Disorder and Melatonin during Fetal Development.
    Jin Y; Choi J; Won J; Hong Y
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29346266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal Stress and Maternal Immune Dysregulation in Autism Spectrum Disorders: Potential Points for Intervention.
    Beversdorf DQ; Stevens HE; Margolis KG; Van de Water J
    Curr Pharm Des; 2019; 25(41):4331-4343. PubMed ID: 31742491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.